These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Creating project plans to focus product development. Wheelwright SC; Clark KB Harv Bus Rev; 1992; 70(2):70-82. PubMed ID: 10117370 [TBL] [Abstract][Full Text] [Related]
4. Rebuilding the R&D engine in big pharma. Garnier JP Harv Bus Rev; 2008 May; 86(5):68-70, 72-6, 128. PubMed ID: 18543809 [TBL] [Abstract][Full Text] [Related]
5. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective. Federsel HJ Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294 [TBL] [Abstract][Full Text] [Related]
7. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach. Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941 [TBL] [Abstract][Full Text] [Related]
8. The economics of pediatric formulation development for off-patent drugs. Milne CP; Bruss JB Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801 [TBL] [Abstract][Full Text] [Related]
9. The triple-A supply chain. Lee HL Harv Bus Rev; 2004 Oct; 82(10):102-12, 157. PubMed ID: 15559579 [TBL] [Abstract][Full Text] [Related]
10. Why are pharmaceutical companies gradually abandoning vaccines? Offit PA Health Aff (Millwood); 2005; 24(3):622-30. PubMed ID: 15886152 [TBL] [Abstract][Full Text] [Related]
11. Making real options really work. van Putten AB; MacMillan IC Harv Bus Rev; 2004 Dec; 82(12):134-41, 150. PubMed ID: 15605572 [TBL] [Abstract][Full Text] [Related]
12. Nontraditional approaches to first-in-human studies to increase efficiency of drug development: will microdose studies make a significant impact? Boyd RA; Lalonde RL Clin Pharmacol Ther; 2007 Jan; 81(1):24-6. PubMed ID: 17185993 [TBL] [Abstract][Full Text] [Related]
13. Stop making plans; start making decisions. Mankins MC; Steele R Harv Bus Rev; 2006 Jan; 84(1):76-84, 133. PubMed ID: 16447371 [TBL] [Abstract][Full Text] [Related]
17. The decision to conduct a head-to-head comparative trial: a game-theoretic analysis. Mansley EC; Elbasha EH; Teutsch SM; Berger ML Med Decis Making; 2007; 27(4):364-79. PubMed ID: 17761957 [TBL] [Abstract][Full Text] [Related]
18. The wisdom of deliberate mistakes. Schoemaker PJ; Gunther RE Harv Bus Rev; 2006 Jun; 84(6):108-15, 146. PubMed ID: 16770898 [TBL] [Abstract][Full Text] [Related]
19. The value captor's process: getting the most out of your new business ventures. McGrath RG; Keil T Harv Bus Rev; 2007 May; 85(5):128-36, 146. PubMed ID: 17494256 [TBL] [Abstract][Full Text] [Related]
20. Delusions of success. How optimism undermines executives' decisions. Lovallo D; Kahneman D Harv Bus Rev; 2003 Jul; 81(7):56-63, 117. PubMed ID: 12858711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]